Japanese guideline for atopic dermatitis

Allergology International

Volumn 60, Issue 2, 2011, Pages 205-220

  Katayama, Ichiro ^a   Kohno, Yoichi ^b   Akiyama, Kazuo ^c   Ikezawa, Zenro ^c   Kondo, Naomi ^d   Tamaki, Kunihiko ^e   Kouro, Osamu ^f  

^a OSAKA UNIVERSITY   (Japan)

^b CHIBA UNIVERSITY   (Japan)

^c YOKOHAMA CITY UNIVERSITY   (Japan)

^d GIFU UNIVERSITY   (Japan)

^e Tamaki Skin Clinic   (Japan)

^f Kouro Skin Clinic   (Japan)

Author keywords

Atopic dermatitis; Exacerbating factors; Guideline; Pharmacotherapy; Skin care

Indexed keywords

ALCOHOL; ANTIALLERGIC AGENT; ANTIBIOTIC AGENT; ANTIHISTAMINIC AGENT; CENTRAL DEPRESSANT AGENT; CHOLINERGIC RECEPTOR BLOCKING AGENT; CROMOGLYCATE DISODIUM; CYCLOSPORIN; CYCLOSPORIN A; CYTOKINE RECEPTOR ANTAGONIST; HYPNOTIC AGENT; IRRITANT AGENT; LEUKOTRIENE RECEPTOR BLOCKING AGENT; MONOAMINE OXIDASE INHIBITOR; OMEGA 3 FATTY ACID; PSYCHOTROPIC AGENT; STEROID; TACROLIMUS; THROMBOXANE A2 RECEPTOR BLOCKING AGENT; TRICYCLIC ANTIDEPRESSANT AGENT;

ABDOMINAL PAIN; ANTIBODY TITER; ANTIINFLAMMATORY ACTIVITY; ANTIMICROBIAL THERAPY; ATOPIC DERMATITIS; BACTERIAL FLORA; CHEMOTHERAPY INDUCED EMESIS; CHILDHOOD; CONTACT DERMATITIS; DEPIGMENTATION; DERMATITIS; DERMATOPHYTOSIS; DIAGNOSTIC TEST; DIARRHEA; DIFFERENTIAL DIAGNOSIS; DISEASE COURSE; DISEASE SEVERITY; DRUG COST; DRUG EFFICACY; DRUG INDUCED HEADACHE; DRUG SAFETY; DRUG USE; DRY SKIN; ENVIRONMENTAL FACTOR; EPIDEMIOLOGICAL DATA; ERYTHEMA; FOLLICULITIS; FOOD ALLERGY; GLAUCOMA; GLUTEAL GRANULOMA; GLYCYRRHIZA; GRANULOMA; HEALTH SURVEY; HEART ARRHYTHMIA; HERBAL MEDICINE; HEREDITY; HUMAN; HYDROPHILICITY; HYPERTENSION; HYPERTRICHOSIS; INCIDENTAL FINDING; INTESTINE OBSTRUCTION; JAPAN; JAPANESE; LABORATORY TEST; MALAISE; MEMORY DISORDER; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS INFECTION; NAUSEA; OINTMENT; PATHOPHYSIOLOGY; PERSONAL HYGIENE; PHOTODYNAMIC THERAPY; PRACTICE GUIDELINE; PRIORITY JOURNAL; PRURITUS; PSYCHOSOMATICS; PSYCHOTHERAPY; PURPURA; QUALITY OF LIFE; RASH; REVIEW; ROSACEA; SECONDARY INFECTION; SEDATION; SIDE EFFECT; SKIN ATROPHY; SKIN CARE; SKIN DISEASE; SOMNOLENCE; STAPHYLOCOCCUS INFECTION; STEROID THERAPY; STRIA; SUBSTITUTION THERAPY; SWEATING; TELANGIECTASIA; TERATOGENICITY; TREATMENT DURATION; TREATMENT PLANNING; TREATMENT RESPONSE; ULTRAVIOLET B RADIATION; UNSPECIFIED SIDE EFFECT; VERTIGO; WEAKNESS; WOUND HEALING IMPAIRMENT; XEROSTOMIA;

EID: 79959590879     PISSN: 13238930     EISSN: 14401592     Source Type: Journal    
DOI: 10.2332/allergolint.11-RAI-0333     Document Type: Review

References (32)

1. Saeki H, Furue M, Furukawa F et al, and COMMITTEE for GUIDELINES for the MANAGEMENT of ATOPIC DERMATITIS of JAPANESE DERMATOLOGICAL ASSOCIATION. Guidelines for management of atopic dermatitis. J Dermatol 2009;36:563-77.
2. Bieber T. Atopic dermatitis. N Engl J Med 2008;358:1483-94.
3. Grewe M, Bruijnzeel-Koomen CA, Schöpf E et al. A role for Th1 and Th2 cells in the immunopathogenesis of atopic dermatitis. Immunol Today 1998;19:359-61.
4. Ong PY, Ohtake T, Brandt C et al. Endogenous antimicrobial peptides and skin infections in atopic dermatitis. N Engl J Med 2002;347:1151-60.
5. Imokawa G, Abe A, Jin K, Higaki Y, Kawashima M, Hidano A. Decreased level of ceramides in stratum corneum of atopic dermatitis: an etiologic factor in atopic dry skin? J Invest Dermatol 1991;96:523-6.
6. Palmer CN, Irvine AD, Terron-Kwiatkowski A et al. Common loss-of-function variants of the epidermal barrier protein filaggrin are a major predisposing factor for atopic dermatitis. Nat Genet 2006;38:441-6.
7. Snkoly E, Muller A, Lauerma A et al. IL-31: a new link between T cells and pruritus in atopic skin inflammation. J Allerg Clin Immunol 2006;117:411-7.
8. Williams H, Robertson C, Stewart A et al. Worldwide variations in the prevalence of symptoms of atopic eczema in the International Study of Asthma and Allergies in Childhood. J Allergy Clin Immunol 1999;103:125-38.
9. Williams H, Stewart A, von Mutius E, Cookson W, Anderson HR; International Study of Asthma and Allergies in Childhood (ISAAC) Phase One and Three Study Groups. Is eczema really on the increase worldwide? J Allergy Clin Immunol 2008;121:947-54. e15.
10. Saeki H, Iizuka H, Mori Y et al. Community validation of the U.K. diagnostic criteria for atopic dermatitis in Japanese elementary schoolchildren. J Dermatol Sci 2007;47: 227-31.
11. Kohno Y. [Identification of Causative and Exacerbation Factors of Atopic Dermatitis and Studies for Improvement of Living Environment to Prevent the Development and Exacerbation of Symptoms. Reports of Research on Allergic Disease and Immunology. Ministry of Health, Labour and Welfare of Japan 2006-2007]. 2008;173-7(in Japanese).
12. Ministry of Health and Welfare Japan. [Psychosomatic Disorders Research]. Tokyo: Nankodo, 1994;56(in Japanese).
13. Hijnen D, De Bruin-Weller M, Oosting B et al. Serum thymus and activation-regulated chemokine (TARC) and cutaneous T cell-attracting chemokine (CTACK) levels in allergic diseases: TARC and CTACK are disease-specific markers for atopic dermatitis. J Allergy Clin Immunol 2004;113:334-40.
14. Aoki T. [Review Committee for Severity Classification of Atopic Dermatitis. Second Report]. [Jpn J Dermatol] 2001; 111:2023-33(in Japanese).
15. Ministry of Health and Welfare, Japan. [Guidelines for the Treatment of Atopic Dermatitis 2008]. 2008(in Japanese).
16. Kobayashi M. [Curettage of Patients with Atopic Dermatitis]. [Jpn J Dermatol] 2000;110:275-82(in Japanese).
17. Sporik R, Holgate ST, Platts-Mills TA, Cogswell JJ. Exposure to house-dust mite allergen (Der p I) and the development of asthma in childhood. A prospective study. N Engl J Med 1990;323:502-7.
18. Yokozeki H, Satoh T, Katayama I, Nishioka K. Airborne contact dermatitis due to Japanese cedar pollen. Contact Dermatitis 2007;56:224-8.
19. Kodama A, Horikawa T, Suzuki T et al. Effect of stress on atopic dermatitis: investigation in patients after the great hanshin earthquake. J Allergy Clin Immunol 1999;104: 173-6.
20. Mochizuki H, Muramatsu R, Tadaki H, Mizuno T, Arakawa H, Morikawa A. Effects of skin care with shower therapy on children with atopic dermatitis in elementary schools. Pediatr Dermatol 2009;26:223-5.
21. Murota H, Takahashi A, Nishioka M et al. Showering reduces atopic dermatitis in elementary school students. Eur J Dermatol 2010;20:410-1.
22. Barnes PJ. Molecular mechanisms and cellular effects of glucocorticosteroids. Immunol Allergy Clin North Am 2005;25:451-68.
23. Katayama I, Kohno Y; Japanese Society of Allergology. [Guidelines for the Management of Atopic Dermatitis 2009]. Tokyo: Kyowa Kikaku, 2009;55-65(in Japanese).
24. Long CC, Finlay AY. The finger-tip unit-a new practical measure. Clin Exp Dermatol 1991;16:444-7.
25. Long CC, Mills CM, Finlay AY. A practical guide to topical therapy in children. Br J Dermatol 1998;138:293-6.
26. Williams HC. Established corticosteroid creams should be applied only once daily in patients with atopic eczema. BMJ 2007;334:1272.
27. Furue M, Terao H, Rikihisa W et al. Clinical dose and adverse effects of topical steroids in daily management of atopic dermatitis. Br J Dermatol 2003;148:128-33.
28. Hanifin JM, Cooper KD, Ho VC et al. Guidelines of care for atopic dermatitis, developed in accordance with the American Academy of Dermatology (AAD)/American Academy of Dermatology Association "Administrative Regulations for Evidence-Based Clinical Practice Guidelines". J AmAcad Dermatol 2004;50:391-404.
29. Wollenberg A, Reitamo S, Girolomoni G et al. Proactive treatment of atopic dermatitis in adults with 0.1% tacrolimus ointment. Allergy 2008;63:742-50.
30. Schneeweiss S, Doherty M, Zhu S et al. Topical treatments with pimecrolimus, tacrolimus and medium-to high-potency corticosteroids, and risk of lymphoma. Dermatology 2009;219:7-21.
31. Murota H, Kitaba S, Tani M et al. Impact of sedative and non-sedative antihistamines on the impaired productivity and quality of life in patients with pruritic skin diseases. Allergol Int 2010;59:345-54.
32. Haw S, Shin MK, Haw CR. The Efficacy and safety of long-term oral cyclosporine treatment for patients with atopic dermatitis. Ann Dermatol 2010;22:9-15.